HIV 백신 개발 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "HIV 백신 개발" in Korean language version.

refsWebsite

Global rank Korean rank

26doi.org

2^nd place

3^rd place

23nih.gov

4^th place

4worldcat.org

5^th place

11^th place

3archive.org

6^th place

18^th place

3harvard.edu

18^th place

27^th place

3semanticscholar.org

11^th place

310^th place

3web.archive.org

1^st place

1medpagetoday.com

9,274^th place

5,896^th place

1oup.com

485^th place

371^st place

1plos.org

2,112^th place

1,114^th place

1foxnews.com

152^nd place

617^th place

1medicaldaily.com

low place

1stepstudies.com

low place

1who.int

195^th place

98^th place

1hvtn.org

low place

1hivresourcetracking.org

low place

1ssrn.com

703^rd place

920^th place

archive.org

Shilts, Randy (1987). 《And the Band Played On: Politics, People, and the AIDS Epidemic》 2007판. St. Martin's Press. 451쪽. ISBN 978-0-312-24135-3.
Kim D, Elizaga M, Duerr A (March 2007). “HIV vaccine efficacy trials: towards the future of HIV prevention”. 《Infectious Disease Clinics of North America》 21 (1): 201–17, x. doi:10.1016/j.idc.2007.01.006. PMID 17502236.
Connor RI, Korber BT, Graham BS, Hahn BH, Ho DD, Walker BD, 외. (February 1998). “Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines”. 《Journal of Virology》 72 (2): 1552–76. doi:10.1128/JVI.72.2.1552-1576.1998. PMC 124637. PMID 9445059.

doi.org

dx.doi.org

Gray, Glenda E; Laher, Fatima; Lazarus, Erica; Ensoli, Barbara; Corey, Lawrence (2016년 4월). “Approaches to preventative and therapeutic HIV vaccines”. 《Current Opinion in Virology》 17: 104–109. doi:10.1016/j.coviro.2016.02.010. ISSN 1879-6257.
Blackham, J (2004년 7월 8일). “2004 update on the global AIDS epidemic from UNAIDS”. 《Weekly releases (1997–2007)》 8 (28). doi:10.2807/esw.08.28.02501-en. ISSN 9999-1233.
“1 October News”. 《Clinical Infectious Diseases》 (영어) 55 (7): i–ii. 2012년 10월 1일. doi:10.1093/cid/cis674. ISSN 1058-4838.
Gray, Glenda E.; Laher, Fatima; Doherty, Tanya; Abdool Karim, Salim; Hammer, Scott; Mascola, John; Beyrer, Chris; Corey, Larry (2016년 3월 2일). “Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?”. 《PLOS Biology》 (영어) 14 (3): e1002372. doi:10.1371/journal.pbio.1002372. ISSN 1545-7885.
Létourneau S, Im EJ, Mashishi T, Brereton C, Bridgeman A, Yang H, Dorrell L, Dong T, Korber B, McMichael AJ, Hanke T (October 2007). Nixon D, 편집. “Design and pre-clinical evaluation of a universal HIV-1 vaccine”. 《PLOS ONE》 2 (10): e984. Bibcode:2007PLoSO...2..984L. doi:10.1371/journal.pone.0000984. PMC 1991584. PMID 17912361.
Kim D, Elizaga M, Duerr A (March 2007). “HIV vaccine efficacy trials: towards the future of HIV prevention”. 《Infectious Disease Clinics of North America》 21 (1): 201–17, x. doi:10.1016/j.idc.2007.01.006. PMID 17502236.
Watkins DI (March 2008). “The hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a review”. 《Memórias do Instituto Oswaldo Cruz》 103 (2): 119–29. doi:10.1590/S0074-02762008000200001. PMC 2997999. PMID 18425263.
Létourneau S, Im EJ, Mashishi T, Brereton C, Bridgeman A, Yang H, Dorrell L, Dong T, Korber B, McMichael AJ, Hanke T (October 2007). Nixon D, 편집. “Design and pre-clinical evaluation of a universal HIV-1 vaccine”. 《PLOS ONE》 2 (10): e984. Bibcode:2007PLoSO...2..984L. doi:10.1371/journal.pone.0000984. PMC 1991584. PMID 17912361.
Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, 외. (April 1999). “Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo”. 《Immunity》 10 (4): 431–8. doi:10.1016/S1074-7613(00)80043-6. PMID 10229186.
Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, 외. (June 1990). “Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160”. 《Nature》 345 (6276): 622–5. Bibcode:1990Natur.345..622B. doi:10.1038/345622a0. PMID 2190095. S2CID 4258128.
Connor RI, Korber BT, Graham BS, Hahn BH, Ho DD, Walker BD, 외. (February 1998). “Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines”. 《Journal of Virology》 72 (2): 1552–76. doi:10.1128/JVI.72.2.1552-1576.1998. PMC 124637. PMID 9445059.
Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, 외. (August 2008). “The use of nonhuman primate models in HIV vaccine development”. 《PLOS Medicine》 5 (8): e173. doi:10.1371/journal.pmed.0050173. PMC 2504486. PMID 18700814.
Marques R, Williams A, Eksmond U, Wullaert A, Killeen N, Pasparakis M, 외. (2009). “Generalized immune activation as a direct result of activated CD4+ T cell killing”. 《Journal of Biology》 8 (10): 93. doi:10.1186/jbiol194. PMC 2790834. PMID 19943952.
Vrisekoop N, Mandl JN, Germain RN (2009). “Life and death as a T lymphocyte: from immune protection to HIV pathogenesis”. 《Journal of Biology》 8 (10): 91. doi:10.1186/jbiol198. PMC 2790836. PMID 19951397.
Bekker LG, Moodie Z, Grunenberg N, Laher F, Tomaras GD, Cohen KW, 외. (June 2018). “Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial”. 《The Lancet. HIV》 5 (7): e366–e378. doi:10.1016/S2352-3018(18)30071-7. PMC 6028742. PMID 29898870.
Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S (July 2014). “Recent progress in HIV vaccines inducing mucosal immune responses”. 《AIDS》 28 (12): 1701–18. doi:10.1097/qad.0000000000000308. PMID 25009956. S2CID 28618851.
Choi E, Michalski CJ, Choo SH, Kim GN, Banasikowska E, Lee S, 외. (November 2016). “First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses”. 《Retrovirology》 13 (1): 82. doi:10.1186/s12977-016-0317-2. PMC 5126836. PMID 27894306.
Sekaly RP (January 2008). “The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?”. 《The Journal of Experimental Medicine》 205 (1): 7–12. doi:10.1084/jem.20072681. PMC 2234358. PMID 18195078.
Iaccino E, Schiavone M, Fiume G, Quinto I, Scala G (July 2008). “The aftermath of the Merck's HIV vaccine trial”. 《Retrovirology》 5: 56. doi:10.1186/1742-4690-5-56. PMC 2483718. PMID 18597681.
Huang Y, Karuna S, Carpp LN, Reeves D, Pegu A, Seaton K, 외. (April 2018). “Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials”. 《Human Vaccines & Immunotherapeutics》 14 (9): 2116–2127. doi:10.1080/21645515.2018.1462640. PMC 6183277. PMID 29683765.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, 외. (April 2016). “Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial”. 《Retrovirology》 13: 21. doi:10.1186/s12977-016-0251-3. PMC 4818470. PMID 27036656.
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, 외. (December 2009). “Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand”. 《The New England Journal of Medicine》 361 (23): 2209–20. doi:10.1056/NEJMoa0908492. PMID 19843557.
Callaway, Ewen (2011년 9월 16일). “Clues emerge to explain first successful HIV vaccine trial”. 《Nature》. doi:10.1038/news.2011.541.
Berndt ER, Glennerster R, Kremer M, Lee J, Levine R, Weizsacker G, 외. (April 2005). “Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness”. 《NBER Working Paper》. doi:10.2139/ssrn.696741. SSRN 696741.
Bagasra O, Bagasra AU, Sheraz M, Pace DG (March 2012). “Potential utility of GB virus type C as a preventive vaccine for HIV-1”. 《Expert Review of Vaccines》 11 (3): 335–47. doi:10.1586/erv.11.191. PMID 22380825. S2CID 26476119.
Wang N, Li Y, Niu W, Sun M, Cerny R, Li Q, Guo J (May 2014). “Construction of a live-attenuated HIV-1 vaccine through genetic code expansion”. 《Angewandte Chemie》 53 (19): 4867–71. doi:10.1002/anie.201402092. PMC 4984542. PMID 24715496.

foxnews.com

“New Vaccine Could Turn HIV Into Minor Infection”. 《Fox News》. 2011년 9월 29일. 2011년 9월 29일에 확인함.

harvard.edu

adsabs.harvard.edu

Létourneau S, Im EJ, Mashishi T, Brereton C, Bridgeman A, Yang H, Dorrell L, Dong T, Korber B, McMichael AJ, Hanke T (October 2007). Nixon D, 편집. “Design and pre-clinical evaluation of a universal HIV-1 vaccine”. 《PLOS ONE》 2 (10): e984. Bibcode:2007PLoSO...2..984L. doi:10.1371/journal.pone.0000984. PMC 1991584. PMID 17912361.
Létourneau S, Im EJ, Mashishi T, Brereton C, Bridgeman A, Yang H, Dorrell L, Dong T, Korber B, McMichael AJ, Hanke T (October 2007). Nixon D, 편집. “Design and pre-clinical evaluation of a universal HIV-1 vaccine”. 《PLOS ONE》 2 (10): e984. Bibcode:2007PLoSO...2..984L. doi:10.1371/journal.pone.0000984. PMC 1991584. PMID 17912361.
Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, 외. (June 1990). “Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160”. 《Nature》 345 (6276): 622–5. Bibcode:1990Natur.345..622B. doi:10.1038/345622a0. PMID 2190095. S2CID 4258128.

hivresourcetracking.org

“Investing to End the AIDS Epidemic: A new Era for HIV Prevention Research and Development” (PDF). 2012년 12월 14일에 원본 문서 (PDF)에서 보존된 문서. 2010년 12월 13일에 확인함.

hvtn.org

Efficacy Results from the STEP Study (Merck V520 Protocol 023/HVTN 502): A Phase II Test-of-Concept Trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent Vaccine 보관됨 2011-07-26 - 웨이백 머신

medicaldaily.com

“New HIV Vaccine Proves Successful In Phase 1 Human Trial”. 《Medical Daily》 (New York). 2013년 9월 4일. 2013년 9월 4일에 확인함.

medpagetoday.com

“The Moon Landing of HIV Vaccine Research: RV144, Ten Years Later”.

nih.gov

ncbi.nlm.nih.gov

Fauci AS (1996). “An HIV vaccine: breaking the paradigms”. 《Proc. Am. Assoc. Phys.》 108 (1): 6–13. PMID 8834058.
Létourneau S, Im EJ, Mashishi T, Brereton C, Bridgeman A, Yang H, Dorrell L, Dong T, Korber B, McMichael AJ, Hanke T (October 2007). Nixon D, 편집. “Design and pre-clinical evaluation of a universal HIV-1 vaccine”. 《PLOS ONE》 2 (10): e984. Bibcode:2007PLoSO...2..984L. doi:10.1371/journal.pone.0000984. PMC 1991584. PMID 17912361.
Kim D, Elizaga M, Duerr A (March 2007). “HIV vaccine efficacy trials: towards the future of HIV prevention”. 《Infectious Disease Clinics of North America》 21 (1): 201–17, x. doi:10.1016/j.idc.2007.01.006. PMID 17502236.
Watkins DI (March 2008). “The hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a review”. 《Memórias do Instituto Oswaldo Cruz》 103 (2): 119–29. doi:10.1590/S0074-02762008000200001. PMC 2997999. PMID 18425263.
Létourneau S, Im EJ, Mashishi T, Brereton C, Bridgeman A, Yang H, Dorrell L, Dong T, Korber B, McMichael AJ, Hanke T (October 2007). Nixon D, 편집. “Design and pre-clinical evaluation of a universal HIV-1 vaccine”. 《PLOS ONE》 2 (10): e984. Bibcode:2007PLoSO...2..984L. doi:10.1371/journal.pone.0000984. PMC 1991584. PMID 17912361.
Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, 외. (April 1999). “Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo”. 《Immunity》 10 (4): 431–8. doi:10.1016/S1074-7613(00)80043-6. PMID 10229186.
Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, 외. (June 1990). “Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160”. 《Nature》 345 (6276): 622–5. Bibcode:1990Natur.345..622B. doi:10.1038/345622a0. PMID 2190095. S2CID 4258128.
Connor RI, Korber BT, Graham BS, Hahn BH, Ho DD, Walker BD, 외. (February 1998). “Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines”. 《Journal of Virology》 72 (2): 1552–76. doi:10.1128/JVI.72.2.1552-1576.1998. PMC 124637. PMID 9445059.
Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, 외. (August 2008). “The use of nonhuman primate models in HIV vaccine development”. 《PLOS Medicine》 5 (8): e173. doi:10.1371/journal.pmed.0050173. PMC 2504486. PMID 18700814.
Marques R, Williams A, Eksmond U, Wullaert A, Killeen N, Pasparakis M, 외. (2009). “Generalized immune activation as a direct result of activated CD4+ T cell killing”. 《Journal of Biology》 8 (10): 93. doi:10.1186/jbiol194. PMC 2790834. PMID 19943952.
Vrisekoop N, Mandl JN, Germain RN (2009). “Life and death as a T lymphocyte: from immune protection to HIV pathogenesis”. 《Journal of Biology》 8 (10): 91. doi:10.1186/jbiol198. PMC 2790836. PMID 19951397.
Bekker LG, Moodie Z, Grunenberg N, Laher F, Tomaras GD, Cohen KW, 외. (June 2018). “Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial”. 《The Lancet. HIV》 5 (7): e366–e378. doi:10.1016/S2352-3018(18)30071-7. PMC 6028742. PMID 29898870.
Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S (July 2014). “Recent progress in HIV vaccines inducing mucosal immune responses”. 《AIDS》 28 (12): 1701–18. doi:10.1097/qad.0000000000000308. PMID 25009956. S2CID 28618851.
Choi E, Michalski CJ, Choo SH, Kim GN, Banasikowska E, Lee S, 외. (November 2016). “First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses”. 《Retrovirology》 13 (1): 82. doi:10.1186/s12977-016-0317-2. PMC 5126836. PMID 27894306.
Sekaly RP (January 2008). “The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?”. 《The Journal of Experimental Medicine》 205 (1): 7–12. doi:10.1084/jem.20072681. PMC 2234358. PMID 18195078.
Iaccino E, Schiavone M, Fiume G, Quinto I, Scala G (July 2008). “The aftermath of the Merck's HIV vaccine trial”. 《Retrovirology》 5: 56. doi:10.1186/1742-4690-5-56. PMC 2483718. PMID 18597681.
Huang Y, Karuna S, Carpp LN, Reeves D, Pegu A, Seaton K, 외. (April 2018). “Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials”. 《Human Vaccines & Immunotherapeutics》 14 (9): 2116–2127. doi:10.1080/21645515.2018.1462640. PMC 6183277. PMID 29683765.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, 외. (April 2016). “Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial”. 《Retrovirology》 13: 21. doi:10.1186/s12977-016-0251-3. PMC 4818470. PMID 27036656.
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, 외. (December 2009). “Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand”. 《The New England Journal of Medicine》 361 (23): 2209–20. doi:10.1056/NEJMoa0908492. PMID 19843557.
Bagasra O, Bagasra AU, Sheraz M, Pace DG (March 2012). “Potential utility of GB virus type C as a preventive vaccine for HIV-1”. 《Expert Review of Vaccines》 11 (3): 335–47. doi:10.1586/erv.11.191. PMID 22380825. S2CID 26476119.
Wang N, Li Y, Niu W, Sun M, Cerny R, Li Q, Guo J (May 2014). “Construction of a live-attenuated HIV-1 vaccine through genetic code expansion”. 《Angewandte Chemie》 53 (19): 4867–71. doi:10.1002/anie.201402092. PMC 4984542. PMID 24715496.

nih.gov

“Experimental HIV vaccine regimen ineffective in preventing HIV”. NIH. 2020년 2월 3일. 2020년 2월 4일에 확인함.
15 July 2019 (2019년 7월 15일). “NIH and partners to launch HIV vaccine efficacy trial in the Americas and Europe”. National Institutes of Health. 2019년 7월 23일에 확인함.

oup.com

academic.oup.com

“1 October News”. 《Clinical Infectious Diseases》 (영어) 55 (7): i–ii. 2012년 10월 1일. doi:10.1093/cid/cis674. ISSN 1058-4838.

plos.org

dx.plos.org

Gray, Glenda E.; Laher, Fatima; Doherty, Tanya; Abdool Karim, Salim; Hammer, Scott; Mascola, John; Beyrer, Chris; Corey, Larry (2016년 3월 2일). “Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?”. 《PLOS Biology》 (영어) 14 (3): e1002372. doi:10.1371/journal.pbio.1002372. ISSN 1545-7885.

semanticscholar.org

api.semanticscholar.org

Berman PW, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, 외. (June 1990). “Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160”. 《Nature》 345 (6276): 622–5. Bibcode:1990Natur.345..622B. doi:10.1038/345622a0. PMID 2190095. S2CID 4258128.
Pavot V, Rochereau N, Lawrence P, Girard MP, Genin C, Verrier B, Paul S (July 2014). “Recent progress in HIV vaccines inducing mucosal immune responses”. 《AIDS》 28 (12): 1701–18. doi:10.1097/qad.0000000000000308. PMID 25009956. S2CID 28618851.
Bagasra O, Bagasra AU, Sheraz M, Pace DG (March 2012). “Potential utility of GB virus type C as a preventive vaccine for HIV-1”. 《Expert Review of Vaccines》 11 (3): 335–47. doi:10.1586/erv.11.191. PMID 22380825. S2CID 26476119.

ssrn.com

Berndt ER, Glennerster R, Kremer M, Lee J, Levine R, Weizsacker G, 외. (April 2005). “Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness”. 《NBER Working Paper》. doi:10.2139/ssrn.696741. SSRN 696741.

stepstudies.com

“STEP Study Locations”. 2008년 7월 24일에 원본 문서에서 보존된 문서. 2008년 11월 4일에 확인함.

web.archive.org

“STEP Study Locations”. 2008년 7월 24일에 원본 문서에서 보존된 문서. 2008년 11월 4일에 확인함.
Efficacy Results from the STEP Study (Merck V520 Protocol 023/HVTN 502): A Phase II Test-of-Concept Trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent Vaccine 보관됨 2011-07-26 - 웨이백 머신
“Investing to End the AIDS Epidemic: A new Era for HIV Prevention Research and Development” (PDF). 2012년 12월 14일에 원본 문서 (PDF)에서 보존된 문서. 2010년 12월 13일에 확인함.

who.int

Joint United Nations Programme on HIV/AIDS (UNAIDS) (December 2005). “AIDS epidemic update” (PDF). World Health Organization. 2014년 4월 22일에 확인함.

worldcat.org

Gray, Glenda E; Laher, Fatima; Lazarus, Erica; Ensoli, Barbara; Corey, Lawrence (2016년 4월). “Approaches to preventative and therapeutic HIV vaccines”. 《Current Opinion in Virology》 17: 104–109. doi:10.1016/j.coviro.2016.02.010. ISSN 1879-6257.
Blackham, J (2004년 7월 8일). “2004 update on the global AIDS epidemic from UNAIDS”. 《Weekly releases (1997–2007)》 8 (28). doi:10.2807/esw.08.28.02501-en. ISSN 9999-1233.
“1 October News”. 《Clinical Infectious Diseases》 (영어) 55 (7): i–ii. 2012년 10월 1일. doi:10.1093/cid/cis674. ISSN 1058-4838.
Gray, Glenda E.; Laher, Fatima; Doherty, Tanya; Abdool Karim, Salim; Hammer, Scott; Mascola, John; Beyrer, Chris; Corey, Larry (2016년 3월 2일). “Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?”. 《PLOS Biology》 (영어) 14 (3): e1002372. doi:10.1371/journal.pbio.1002372. ISSN 1545-7885.